Myths about the treatment of addiction

Lancet

Volumn 347, Issue 8996, 1996, Pages 237-240

  O'Brien, Charles P ^a   McLellan, A Thomas ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADDICTION; ATTITUDE; CHRONIC DISEASE; DETOXIFICATION; HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RELAPSE; SHORT SURVEY; TREATMENT FAILURE;

EID: 0030023451     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90409-2     Document Type: Article

References (34)

1. Mattick RP, Hall W. Are detoxification programmes effective? Lancet 1996; 347: 97-100.
2. Schuckit MA. Low level of response to alcohol. Am J Psychiatry 1994; 151: 184-89.
3. Gerstein D, Harwood H. Treating drug problems. Vol I. Washington, DC: National Academy Press, 1990.
4. Gerstein D, Judd LL, Rovner SA. Career dynamics of female heroin addicts. Am J Drug Alcohol Abuse 1979; 6: 1-23.
5. Miller WR, Hester RK. The effectiveness of alcoholism treatment methods: what research reveals. In: Miller WR, Heather N, eds. Treating addictive behaviors: process of change. New York: Plenum Press, 1986.
6. Armor DJ, Polich JM, Stambul HB. Alcoholism and treatment. Santa Monica, California: RAND Corporation Press, 1976.
7. McLellan AT, Luborsky L, O'Brien CP, Woody GE. An improved evaluation instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis 1980; 168: 26-33.
8. Institute of Medicine. Prevention and treatment of alcohol problems: research opportunities. Washington, DC: National Academy Press, 1989.
9. Ball JC, Ross A. The effectiveness of methadone maintenance treatment. New York: Springer-Verlag, 1991.
10. Higgins ST, Budney AJ, Bickel WK, Foerg F, Donham R, Badger GJ. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Arch Gen Psychiatry 1994; 51: 568-76.
11. Fiore MC, Smith SS, Jorenby DE, Baker TB. The effectiveness of the nicotine patch for smoking cessation. JAMA 1994; 271: 1940-46.
12. Gerstein DR, Harwood H, Suter N. Evaluating recovery services: the California Drug and Alcohol Treatment Assessment (CALDATA). California Department of Alcohol and Drug Programs Executive Summary: Publication no. ADP94-628, 1994.
13. Moos RH, Finney JW, Cronkite RC. Alcoholism treatment: context, process and outcome. New York: Oxford University Press, 1990.
14. Simpson D, Savage L. Drug abuse treatment readmissions and outcomes. Arch Gen Psychiatry 1980; 37: 896-901.
15. Hubbard RL, Marsden ME, Rachal JV, Harwood HJ, Cavanaugh ER, Ginzburg HM. Drug abuse treatment: a national study of effectiveness. Chapel Hill: University of North Carolina Press, 1989.
16. DeLeon G. The therapeutic community: study of effectiveness. Treatment research monograph 84-1286. Rockville, MD: National Institute for Drug Abuse, 1994.
17. Havassy BE, Wasserman D, Hall SM. Social relationships and cocaine use in an American treatment sample. Addiction 1995; 90: 699-710.
18. McLellan AT, Druley KA, O'Brien CP, Kron R. Matching substance abuse patients to appropriate treatments. A conceptual and methodological approach. Drug Alcohol Dependence 1980; 5: 189-93.
19. Alterman AI, Cacciola JS. The antisocial personality disorder in substance abusers: problems and issues. J Nerv Mental Dis 1991; 179: 401-09.
20. Fuller RK, Branchey L, Brightwell DR, et al. Disfulfiram treatment of alcoholism. JAMA 1986; 256: 1449-55.
21. O'Brien CP, Woody GE, McLellan AT. A new tool in the treatment of impaired physicians. Philadelphia Med 1986; 82: 442-46.
22. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992; 49: 876-80.
23. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. Arch Gen Psychiatry 1992; 49: 881-87.
24. Graber AL, Davidson P, Brown A, McRae J, Woolridge K. Dropout and relapse during diabetes care. Diabetic Care 1992; 15: 1477-83.
25. Horowitz RI. Treatment adherence and risk of death after a myocardial infarction. Lancet 1990; 336: 542-45.
26. Dekker FW, Dieleman FE, Kaptein AA, Mulder JD. Compliance with pulmonary medication in general practice. Eur Resp J 1993; 6: 886-90.
27. Clark LT. Improving compliance and increasing control of hypertension: needs of special hypertensive populations. Am Heart J 1991; 121: 664-69.
28. Kurtz SM. Adherence to diabetic regimes: empirical status and clinical applications. Diabetes Educ 1990; 16: 50-59.
29. Sinnock P. Hospitalizaton of diabetes. Diabetes data, national diabetes data group. Bethesda MD: National Institutes of Health, 1985.
30. Herman WH, Teutsch SM. Diabetic renal disorders. Diabetes data, national diabetes data group. Bethesda MD: National Institutes of Health, 1985.
31. Schaub AF, Steiner A, Vetter W. Compliance to treatment. J Clin Exp Hypertension 1993; 15: 1121-30.
32. Gorlin R. Hypertension and ischemic heart disease: the challenge of the 1990s. Am Heart J 1991; 121: 658-63.
33. National Center for Health Statistics. Pubic use datatape documentation, Hyattsville, MD: The Center, 1989.
34. Harrison WH. Internal medicine. New York: Raven Press, 1993.